Newton, Massachusetts, United States The main office of represented VC is situated in the Newton. The venture was found in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Tricida, Ra Pharmaceuticals.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Limulus Venture Partners, startups are often financed by Sibling Capital, OrbiMed, Vivo Capital. The meaningful sponsors for the fund in investment in the same round are Sibling Capital, OrbiMed, Vivo Capital. In the next rounds fund is usually obtained by Sibling Capital, OrbiMed, Vivo Capital.
The higher amount of exits for fund were in 2018. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2015. Comparing to the other companies, this Limulus Venture Partners performs on 11 percentage points more the average number of lead investments.
Funds with similar focus
| Fund Name | Location |
| Alpha Capital | Chicago, Illinois, United States |
| Compo Seven Capital | - |
| Harlequin Corporate Finance | England, Oxton, United Kingdom |
| Know Diabetes by Heart | - |
| Mitsui Fudosan | Chiyoda, Japan |
| Summit Bridge Capital | Dublin, Dublin, Ireland |
| Wuxi Jianfa | China, Jiangsu, Wuxi Shi |
| XR Invest | - |
| Zhejiang Huixian Venture Capital | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tricida | $55M | 25 Jul 2016 | California, United States | ||
Ra Pharmaceuticals | $58M | 23 Jul 2015 | Cambridge, Massachusetts, United States | ||
Tricida | $30M | 04 Mar 2015 | California, United States | ||
Tricida | $10M | 04 Sep 2014 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tricida | $55M | 25 Jul 2016 | California, United States | ||
Ra Pharmaceuticals | $58M | 23 Jul 2015 | Cambridge, Massachusetts, United States | ||
Tricida | $30M | 04 Mar 2015 | California, United States | ||
Tricida | $10M | 04 Sep 2014 | California, United States |
